Ivabradine is not associated with higher risk of new onset atrial fibrillation among patients with cardiac resynchronization therapy
27 August 2018 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
ULS Entre Douro e Vouga, Santa Maria da Feira (Portugal)
5 More presentations in this session
Access the full session
The Event
ESC Congress 2018
27 August 2018
08:30 CET
